Arsanis, Inc. Uncategorized Contracts & Agreements

22 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Pre-Funded
Arsanis, Inc.
Biotechnology
DE
2022
Third Amendment to Option Agreement, dated July 15, 2021, by and between X4 Pharmaceuticals, Inc. and Abingworth Bioventures 8 LP
Arsanis, Inc.
Biotechnology
DE
2021
Second Amendment to Option Agreement, dated June 7, 2021, by and between X4 Pharmaceuticals, Inc. and Abingworth Bioventures 8 LP
Arsanis, Inc.
Biotechnology
DE
2021
First Amendment to Option Agreement dated May 3, 2021, by and between X4 Pharmaceuticals Inc. and Abingworth Bioventures 8 LP
Arsanis, Inc.
Biotechnology
DE
2021
Option Agreement, dated March 18, 2021, by and between X4 Pharmaceuticals, Inc. and Abingworth Bioventures 8 LP
Arsanis, Inc.
Biotechnology
DE
2021
Description of Registered Securities
Arsanis, Inc.
Biotechnology
2021
Description of Registered Securities
Arsanis, Inc.
Biotechnology
2020
Letter Agreement, dated November 26, 2018, by and between Arsanis, Inc. and Ren Russo
Arsanis, Inc.
Biotechnology
MA
2018
Form of Support Agreement, dated November 26, 2018, by and among Arsanis, Inc., X4 Pharmaceuticals, Inc. and certain officers, directors and stockholders of X4 Pharmaceuticals, Inc
Arsanis, Inc.
Biotechnology
DE
2018
Form of Support Agreement, dated November 26, 2018, by and among Arsanis, Inc., X4 Pharmaceuticals, Inc. and certain stockholders of Arsanis, Inc
Arsanis, Inc.
Biotechnology
DE
2018
Grant Agreement, dated August 8, 2018, by and between the Registrant and the Bill & Melinda Gates Foundation
Arsanis, Inc.
Biotechnology
2018
Amended and Restated Agreement, dated August 8, 2018, by and between the Registrant and the Bill & Melinda Gates Foundation
Arsanis, Inc.
Biotechnology
GA
2018
ARSANIS, INC. SECONDAMENDED AND RESTATED STOCKHOLDERS AGREEMENT Dated as of April 12, 2016 Amended as of November 3, 2017 TABLE OF CONTENTS
Arsanis, Inc.
Biotechnology
DE
2017
Amended and Restated Offer Letter, dated October 10, 2017, by and between the Registrant and Chris Stevens (to be effective upon the closing of this offering)
Arsanis, Inc.
Biotechnology
2017
Amended and Restated Offer Letter, dated October 10, 2017, by and between the Registrant and Michael Gray (to be effective upon the closing of this offering)
Arsanis, Inc.
Biotechnology
2017
Amended and Restated Offer Letter, dated October 10, 2017, by and between the Registrant and Ren Russo (to be effective upon the closing of this offering)
Arsanis, Inc.
Biotechnology
2017
Second Amended and Restated Stockholders Agreement, dated as of April 12, 2016, among the Registrant and the other parties thereto, as amended
Arsanis, Inc.
Biotechnology
DE
2017
Letter agreement, dated as of April 24, 2017, by and between the Registrant and Bill & Melinda Gates Foundation
Arsanis, Inc.
Biotechnology
DE
2017
Grant Agreement, dated February 20, 2017, by and between the Registrant and Bill & Melinda Gates Foundation, as amended
Arsanis, Inc.
Biotechnology
GA
2017
Offer letter, dated April 28, 2016, by and between the Registrant and Chris Stevens
Arsanis, Inc.
Biotechnology
2017
Offer letter, dated January 15, 2016, by and between the Registrant and Michael Gray
Arsanis, Inc.
Biotechnology
2017
Offer letter, dated July 12, 2015, by and between the Registrant and Ren Russo
Arsanis, Inc.
Biotechnology
2017